Progress in clinical application of spiral CT in efficacy evaluation of transformation therapy for advanced gastric cancer_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

YU Hualong ,  ZHANG Yifei ,  JIANG Lixin

The First Department of Gastrointestinal Surgery, Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, Shandong 264000, P. R. China;

Corresponding author：

ZHANG Yifei, Email: zyfaf@sina.com; JIANG Lixin, Email: jianglixin1969@hotmail.com

Keywords：

spiral CT; advanced gastric cancer; transformation therapy; efficacy evaluation

DOI：

10.7507/1007-9424.201904008

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To summarize controversy and progress of multi-slice spiral CT in efficacy evaluation of transformation therapy for advanced gastric cancer.Method The recent studies published at home and abroad on the spiral CT in evaluating the therapeutic effect of transformation therapy for the advanced gastric cancer were reviewed and analyzed.Results In recent years, though the energy spectrum and dual-energy CT examinations had appeared, the most common tool in evaluating of the efficacy of transformation therapy for the advanced gastric cancer was the spiral CT. The most common evaluation standard was still the RECIST standard.Conclusions Spiral CT has its outstanding diagnostic significance in therapeutic evaluation of transformation therapy for advanced gastric cancer. Although there is some controversy, with advancements of a large number of studies, it will greatly help diagnosis and treatment of advanced gastric cancer.

Citation： YU Hualong, ZHANG Yifei, JIANG Lixin. Progress in clinical application of spiral CT in efficacy evaluation of transformation therapy for advanced gastric cancer. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2019, 26(11): 1367-1371. doi: 10.7507/1007-9424.201904008 Copy

1.	李子禹, 薛侃, 季加孚. 晚期胃癌转化治疗中基于手术的分型. 中华胃肠外科杂志, 2017, 20(7): 721-725.
2.	Lordick F, Luber B, Lorenzen S, et al. Cetuximab plus oxaliplatin/leucovorin/5-fluorouracil in first-line metastatic gastric cancer: a phase Ⅱ study of the Arbeitsgemeinschaft Internistische Onkologie (AIO). Br J Cancer, 2010, 102(3): 500-505.
3.	Enzinger PC, Burtness BA, Niedzwiecki D, et al. CALGB 80403(Alliance)/E1206: A randomized phase Ⅱ study of three chemotherapy regimens plus cetuximab in metastatic esophageal and gastroesophageal junction cancers. J Clin Oncol, 2016, 34(23): 2736-2742.
4.	Jang KM, Kim SH, Lee SJ, et al. Upper abdominal gadoxetic acid-enhanced and diffusion-weighted MRI for the detection of gastric cancer: Comparison with two-dimensional multidetector row CT. Clin Radiol, 2014, 69(8): 827-835.
5.	王杰夫, 雷尚通, 李国新. 64层螺旋CT血管三维重建对胃周动脉的显示能力及其临床意义. 中华胃肠外科杂志, 2015, 18(3): 248-251.
6.	赵群, 李勇, 胡子龙, 等. 多层螺旋CT对胃癌术前分期及肿瘤最长径的评估价值. 中华胃肠外科杂志, 2015, 18(3): 227-231.
7.	Amin MB, Greene FL, Edge SB, et al. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more " personalize” approach to cancer staging. CA Cancer J Clin, 2017, 67(2): 93-99.
8.	唐磊. 从UICC/AJCC第8版TNM分期看胃癌影像学T分期的发展方向. 中华胃肠外科杂志, 2017, 20(7): 735-739.
9.	Kim TU, Kim S, Lee JW, et al. MDCT features in the differentiation of T4a gastric cancer from less-advanced gastric cancer: significance of the hyperattenuating serosa sign. Br J Radiol, 2013, 86(1029): 20130290.
10.	Lee SL, Ku YM, Jeon HM, et al. Impact of the cross-sectional location of multidetector computed tomography scans on prediction of serosal exposure in patients with advanced gastric cancer. Ann Surg Oncol, 2017, 24(4): 1003-1009.
11.	左阳, 刘丽东, 苏丹柯, 等. CT 强化值在表现不典型 T4a 期胃癌分期诊断中的应用价值. 实用放射学杂志, 2015, 31(8): 1283-1286.
12.	郭振江, 李志霞. 关于胃癌术前分期的研究进展. 中华临床医师杂志(电子版), 2013, 7(10): 4456-4458.
13.	姜跃龙, 吴曦, 王征, 等. 环扫超声胃镜在进展期胃癌术前TN分期中的应用分析. 中华消化内镜杂志, 2017, 34(6): 394-399.
14.	刘建梅. 螺旋CT增强扫描在胃癌淋巴结转移中的诊断价值. 河南医学研究, 2017, 26(22): 4149-4150.
15.	刘勇, 陈中银, 冯燕, 等. 多层螺旋CT增强扫描对胃癌浸润程度及淋巴结转移的诊断价值. 山西医药杂志, 2017, 46(3): 289-291.
16.	Fairweather M, Jajoo K, Sainani N, et al. Accuracy of EUS and CT imaging in preoperative gastric cancer staging. J Surg Oncol, 2015, 111(8): 1016-1020.
17.	Koyama T, Mikami Y, Saga T, et al. Secondary ovarian tumors: spectrum of CT and MR features with pathologic correlation. Abdom Imaging, 2007, 32(6): 784-795.
18.	孙娜娜, 刘畅, 冯秋霞, 等. 胃癌腹膜腔转移CT检查的影像学表现. 中华消化外科杂志, 2017, 16(11): 1154-1159.
19.	顾爱燕, 李慧, 张爱娟. 多层螺旋CT在胃癌术前新辅助化疗临床分期中应用价值. 现代仪器与医疗, 2017, 23(4): 3-5.
20.	Choi H, Charnsangavej C, Faria SC, et al. Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria. J Clin Oncol, 2007, 25(13): 1753-1759.
21.	Liu K, Li G, Fan C, et al. Adapted Choi response criteria for prediction of clinical outcome in locally advanced gastric cancer patients following preoperative chemotherapy. Acta Radiol, 2012, 53(2): 127-134.
22.	Luo Y, Chen J, Huang K, et al. Early evaluation of sunitinib for the treatment of advanced gastroenteropancreatic neuroendocrine neoplasms via CT imaging: RECIST 1.1 or Choi Criteria? BMC Cancer, 2017, 17(1): 154.
23.	康毓芝. 检测血清肿瘤标志物对诊断胃癌的临床意义. 实用癌症杂志, 2019, 34(5): 721-723.
24.	王霄霄, 单秀红, 潘冬刚, 等. MSCT对胃癌转移淋巴结的诊断价值. 实用放射学杂志, 2017, 33(5): 695-699.
25.	D’Elia F, Zingarelli A, Palli D, et al. Hydro-dynamic CT preoperative staging of gastric cancer: correlation with pathological findings. A prospective study of 107 cases. Eur Radiol, 2000, 10(12): 1877-1885.
26.	钟宝元, 刘艳秀, 黄文峰, 等. 64层CT三期动态增强扫描对胃癌术前TNM分期的判断价值. 中华胃肠外科杂志, 2012, 15(7): 706-709.
27.	王睿, 李靖, 梁盼, 等. 能谱CT术前预测胃腺癌淋巴结转移的价值. 临床放射学杂志, 2019, 38(3): 469-474.
28.	杜江华, 聂聪科, 王云玲. 能量CT与PET/CT成像在胃癌淋巴结评估中的应用价值. 临床消化病杂志, 2018, 30(1): 10-14.
29.	杜江华, 韩秉艳, 宋娟, 等. 双源CT标准化碘浓度及能谱曲线在胃癌周围侵犯诊断中的应用价值. 医学影像学杂志, 2018, 28(3): 426-430.
30.	白少君. 胃癌螺旋CT三期增强表现特征及诊断价值分析. 中国CT和MRI杂志, 2018, 16(4): 128-130.
31.	Cheng J, Feng C, Zhang Y, et al. CT-detected extramural vessel invasion and regional lymph node involvement in stage T4a gastric cancer for predicting progression-free survival. AJR Am J Roentgenol, 2019: 1-7.
32.	冯渭昌, 庄伟雄, 童志明, 等. CT能谱成像在良恶性纵隔淋巴结鉴别诊断中的价值分析. 生物医学工程学进展, 2016, 37(4): 204-206.
33.	韩建国, 任道凌, 韩明山. ¹⁸F-脱氧葡萄糖PET-CT与腹部增强CT检查对腹膜转移瘤的诊断价值. 中国医药导报, 2015, 12(22): 132-135.
34.	Choi JY, Shim KN, Kim SE, et al. The clinical value of ¹⁸F-fluorodeoxyglucose uptake on positron emission tomography/computed tomography for predicting regional lymph node metastasis and non-curative surgery in primary gastric carcinoma. Korean J Gastroenterol, 2014, 64(6): 340-347.
35.	Chen X, Ren K, Liang P, et al. Association between spectral computed tomography images and clinicopathological features in advanced gastric adenocarcinoma. Oncol Lett, 2017, 14(6): 6664-6670.
36.	王云玲, 宋娟, 杜江华, 等. 双源CT能谱成像定性评估胃癌转移淋巴结. 中国医学影像技术, 2018, 34(5): 705-708.
37.	Tang L, Li ZY, Li ZW, et al. Evaluating the response of gastric carcinomas to neoadjuvant chemotherapy using iodine concentration on spectral CT: a comparison with pathological regression. Clin Radiol, 2015, 70(11): 1198-1204.
38.	Hou Z, Yang Y, Li S, et al. Radiomic analysis using contrast-enhanced CT: predict treatment response to pulsed low dose rate radiotherapy in gastric carcinoma with abdominal cavity metastasis. Quant Imaging Med Surg, 2018, 8(4): 410-420.

1. 李子禹, 薛侃, 季加孚. 晚期胃癌转化治疗中基于手术的分型. 中华胃肠外科杂志, 2017, 20(7): 721-725.
2. Lordick F, Luber B, Lorenzen S, et al. Cetuximab plus oxaliplatin/leucovorin/5-fluorouracil in first-line metastatic gastric cancer: a phase Ⅱ study of the Arbeitsgemeinschaft Internistische Onkologie (AIO). Br J Cancer, 2010, 102(3): 500-505.
3. Enzinger PC, Burtness BA, Niedzwiecki D, et al. CALGB 80403(Alliance)/E1206: A randomized phase Ⅱ study of three chemotherapy regimens plus cetuximab in metastatic esophageal and gastroesophageal junction cancers. J Clin Oncol, 2016, 34(23): 2736-2742.
4. Jang KM, Kim SH, Lee SJ, et al. Upper abdominal gadoxetic acid-enhanced and diffusion-weighted MRI for the detection of gastric cancer: Comparison with two-dimensional multidetector row CT. Clin Radiol, 2014, 69(8): 827-835.
5. 王杰夫, 雷尚通, 李国新. 64层螺旋CT血管三维重建对胃周动脉的显示能力及其临床意义. 中华胃肠外科杂志, 2015, 18(3): 248-251.
6. 赵群, 李勇, 胡子龙, 等. 多层螺旋CT对胃癌术前分期及肿瘤最长径的评估价值. 中华胃肠外科杂志, 2015, 18(3): 227-231.
7. Amin MB, Greene FL, Edge SB, et al. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more " personalize” approach to cancer staging. CA Cancer J Clin, 2017, 67(2): 93-99.
8. 唐磊. 从UICC/AJCC第8版TNM分期看胃癌影像学T分期的发展方向. 中华胃肠外科杂志, 2017, 20(7): 735-739.
9. Kim TU, Kim S, Lee JW, et al. MDCT features in the differentiation of T4a gastric cancer from less-advanced gastric cancer: significance of the hyperattenuating serosa sign. Br J Radiol, 2013, 86(1029): 20130290.
10. Lee SL, Ku YM, Jeon HM, et al. Impact of the cross-sectional location of multidetector computed tomography scans on prediction of serosal exposure in patients with advanced gastric cancer. Ann Surg Oncol, 2017, 24(4): 1003-1009.
11. 左阳, 刘丽东, 苏丹柯, 等. CT 强化值在表现不典型 T4a 期胃癌分期诊断中的应用价值. 实用放射学杂志, 2015, 31(8): 1283-1286.
12. 郭振江, 李志霞. 关于胃癌术前分期的研究进展. 中华临床医师杂志(电子版), 2013, 7(10): 4456-4458.
13. 姜跃龙, 吴曦, 王征, 等. 环扫超声胃镜在进展期胃癌术前TN分期中的应用分析. 中华消化内镜杂志, 2017, 34(6): 394-399.
14. 刘建梅. 螺旋CT增强扫描在胃癌淋巴结转移中的诊断价值. 河南医学研究, 2017, 26(22): 4149-4150.
15. 刘勇, 陈中银, 冯燕, 等. 多层螺旋CT增强扫描对胃癌浸润程度及淋巴结转移的诊断价值. 山西医药杂志, 2017, 46(3): 289-291.
16. Fairweather M, Jajoo K, Sainani N, et al. Accuracy of EUS and CT imaging in preoperative gastric cancer staging. J Surg Oncol, 2015, 111(8): 1016-1020.
17. Koyama T, Mikami Y, Saga T, et al. Secondary ovarian tumors: spectrum of CT and MR features with pathologic correlation. Abdom Imaging, 2007, 32(6): 784-795.
18. 孙娜娜, 刘畅, 冯秋霞, 等. 胃癌腹膜腔转移CT检查的影像学表现. 中华消化外科杂志, 2017, 16(11): 1154-1159.
19. 顾爱燕, 李慧, 张爱娟. 多层螺旋CT在胃癌术前新辅助化疗临床分期中应用价值. 现代仪器与医疗, 2017, 23(4): 3-5.
20. Choi H, Charnsangavej C, Faria SC, et al. Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria. J Clin Oncol, 2007, 25(13): 1753-1759.
21. Liu K, Li G, Fan C, et al. Adapted Choi response criteria for prediction of clinical outcome in locally advanced gastric cancer patients following preoperative chemotherapy. Acta Radiol, 2012, 53(2): 127-134.
22. Luo Y, Chen J, Huang K, et al. Early evaluation of sunitinib for the treatment of advanced gastroenteropancreatic neuroendocrine neoplasms via CT imaging: RECIST 1.1 or Choi Criteria? BMC Cancer, 2017, 17(1): 154.
23. 康毓芝. 检测血清肿瘤标志物对诊断胃癌的临床意义. 实用癌症杂志, 2019, 34(5): 721-723.
24. 王霄霄, 单秀红, 潘冬刚, 等. MSCT对胃癌转移淋巴结的诊断价值. 实用放射学杂志, 2017, 33(5): 695-699.
25. D’Elia F, Zingarelli A, Palli D, et al. Hydro-dynamic CT preoperative staging of gastric cancer: correlation with pathological findings. A prospective study of 107 cases. Eur Radiol, 2000, 10(12): 1877-1885.
26. 钟宝元, 刘艳秀, 黄文峰, 等. 64层CT三期动态增强扫描对胃癌术前TNM分期的判断价值. 中华胃肠外科杂志, 2012, 15(7): 706-709.
27. 王睿, 李靖, 梁盼, 等. 能谱CT术前预测胃腺癌淋巴结转移的价值. 临床放射学杂志, 2019, 38(3): 469-474.
28. 杜江华, 聂聪科, 王云玲. 能量CT与PET/CT成像在胃癌淋巴结评估中的应用价值. 临床消化病杂志, 2018, 30(1): 10-14.
29. 杜江华, 韩秉艳, 宋娟, 等. 双源CT标准化碘浓度及能谱曲线在胃癌周围侵犯诊断中的应用价值. 医学影像学杂志, 2018, 28(3): 426-430.
30. 白少君. 胃癌螺旋CT三期增强表现特征及诊断价值分析. 中国CT和MRI杂志, 2018, 16(4): 128-130.
31. Cheng J, Feng C, Zhang Y, et al. CT-detected extramural vessel invasion and regional lymph node involvement in stage T4a gastric cancer for predicting progression-free survival. AJR Am J Roentgenol, 2019: 1-7.
32. 冯渭昌, 庄伟雄, 童志明, 等. CT能谱成像在良恶性纵隔淋巴结鉴别诊断中的价值分析. 生物医学工程学进展, 2016, 37(4): 204-206.
33. 韩建国, 任道凌, 韩明山. ¹⁸F-脱氧葡萄糖PET-CT与腹部增强CT检查对腹膜转移瘤的诊断价值. 中国医药导报, 2015, 12(22): 132-135.
34. Choi JY, Shim KN, Kim SE, et al. The clinical value of ¹⁸F-fluorodeoxyglucose uptake on positron emission tomography/computed tomography for predicting regional lymph node metastasis and non-curative surgery in primary gastric carcinoma. Korean J Gastroenterol, 2014, 64(6): 340-347.
35. Chen X, Ren K, Liang P, et al. Association between spectral computed tomography images and clinicopathological features in advanced gastric adenocarcinoma. Oncol Lett, 2017, 14(6): 6664-6670.
36. 王云玲, 宋娟, 杜江华, 等. 双源CT能谱成像定性评估胃癌转移淋巴结. 中国医学影像技术, 2018, 34(5): 705-708.
37. Tang L, Li ZY, Li ZW, et al. Evaluating the response of gastric carcinomas to neoadjuvant chemotherapy using iodine concentration on spectral CT: a comparison with pathological regression. Clin Radiol, 2015, 70(11): 1198-1204.
38. Hou Z, Yang Y, Li S, et al. Radiomic analysis using contrast-enhanced CT: predict treatment response to pulsed low dose rate radiotherapy in gastric carcinoma with abdominal cavity metastasis. Quant Imaging Med Surg, 2018, 8(4): 410-420.

Previous Article
Research progress of residual nodules after thermal ablation for benign thyroid nodules
Next Article
Advances of relationship between p53 gene family and thyroid cancer

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Progress in clinical application of spiral CT in efficacy evaluation of transformation therapy for advanced gastric cancer

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content